International Biotechnology Trust (IBT)

Category Sector Equity Biotechnology
star-filledstar-filledstar-filledstar-filled
This investment trust can be held in an Investment ISA, SIPP and Investment Account
Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% or a dash please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.

If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
Sell

980.00p

Buy

992.00p

arrow-up16.00p (+1.64%)

Discount/Premium

-6.03%

Estimated NAV

1,053.564p

Prices updated at 12 Dec 2025, 16:43 GMT
| Prices minimum 15 mins delay
|
Prices in GBX
Investment objective
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
FTSE All-Share
arrow-down-0.48%
LSE
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Annual performance (%)

Year
chevron-l-regular
chevron-r-regular
This fundPeer group index
30 Sep 14 - 30 Sep 1541.6322.22
30 Sep 15 - 30 Sep 1620.331.03
30 Sep 16 - 30 Sep 1715.017.72
30 Sep 17 - 30 Sep 1816.21-0.09
30 Sep 18 - 30 Sep 19-6.1916.12
30 Sep 19 - 30 Sep 2036.4951.10
30 Sep 20 - 30 Sep 21-4.284.72
30 Sep 21 - 30 Sep 22-6.26-11.75
30 Sep 22 - 30 Sep 23-0.34-14.43
30 Sep 23 - 30 Sep 2411.8723.92
30 Sep 24 - 30 Sep 2518.88-7.55

Primary benchmark: Nasdaq Biotechnology Index

Peer group index: Morningstar IT Biotechnology & Healthcare

Trailing returns (%)

Year
chevron-l-regular
chevron-r-regular
This fundPeer group index
1 Day1.640.97
1 Month12.244.70
3 Months43.4820.73
6 Months65.8832.01
1 Year45.4616.07
3 Years annualised18.234.75
5 Years annualised8.38-0.02

Primary benchmark: Nasdaq Biotechnology Index

Peer group index: Morningstar IT Biotechnology & Healthcare

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2025 Morningstar. All rights reserved.